2,226
Views
3
CrossRef citations to date
0
Altmetric
Gastroenterology

Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 691-699 | Received 17 Jan 2023, Accepted 24 Mar 2023, Published online: 11 Apr 2023

Figures & data

Figure 1. Structure of the health economic model.

Figure 1. Structure of the health economic model.

Figure 2. Tornado diagrams from DSA, change in incremental cost of remimazolam compared to midazolam and propofol in colonoscopies and midazolam in bronchoscopies.

Figure 2. Tornado diagrams from DSA, change in incremental cost of remimazolam compared to midazolam and propofol in colonoscopies and midazolam in bronchoscopies.

Table 1. Time-use (in minutes) and presence of HCPs during colonoscopies and bronchoscopies by procedural sedation.

Table 2. Procedure outcomes and use of rescue sedative medication.

Table 3. Unit costs.

Table 4. Results: procedural sedation in colonoscopies.

Supplemental material

Supplemental Material

Download MS Word (31.7 KB)